OREXIGEN THERAPEUTICS INC

CUSIP: 686164AB0 Class: CONV

OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM's Holding History (CIK: 0001132716)

Note: Option positions (PUT/CALL) are excluded.

Q4 2017
Shares 7,500,000 Value ($000) $2,780,000 Avg Close — Range —
Q3 2017
Shares 7,500,000 Value ($000) $3,000,000 Avg Close — Range —
Q2 2017
Shares 7,500,000 Value ($000) $3,000,000 Avg Close — Range —
Q1 2017
Shares 7,500,000 Value ($000) $3,000,000 Avg Close — Range —
Q4 2016
Shares 15,000,000 Value ($000) $3,750,000 Avg Close — Range —
Q3 2016
Shares 21,414,000 Value ($000) $5,934,000 Avg Close — Range —
Q2 2016
Shares 21,414,000 Value ($000) $8,452,000 Avg Close — Range —
Q1 2016
Shares 21,414,000 Value ($000) $8,975,000 Avg Close — Range —
Q4 2015
Shares 20,664,000 Value ($000) $12,519,000 Avg Close — Range —
Q3 2015
Shares 19,075,000 Value ($000) $13,438,000 Avg Close — Range —
Q2 2015
Shares 16,075,000 Value ($000) $14,928,000 Avg Close — Range —
Q1 2015
Shares 15,000,000 Value ($000) $17,219,000 Avg Close — Range —
Q4 2014
Shares 9,500,000 Value ($000) $9,579,000 Avg Close — Range —